image
imagewidth (px) 288
763
| latex
stringlengths 253
5.23k
|
|---|---|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|l|l|l|l|l|l|l|}
\hline
& & & \multicolumn{2}{c|}{Minimally} & ORa & & & & & & & \multicolumn{2}{c|}{Fully adjusted} \\
\hline
& & \multicolumn{2}{c|}{African-American} & & & White & & & \multicolumn{3}{c|}{African-American} & & & \multicolumn{2}{c|}{White} \\
\hline
& Case & Control & OR & 95% CI & Case & Control & OR & 95% CI & Case & Control & OR & 95% CI & Case & Control & OR & 95% CI \\
\hline
Full CBCSc & n = 331 & n = 329 & & & n = 523 & n = 456 & & & n = 331 & n = 329 & & & n = 523 & n = 456 \\
\hline
1st born (ref.) & 106 & 103 & Ref. & & 191 & 165 & Ref. & & 106 & 103 & Ref. & & 191 & 165 & Ref. \\
\hline
2nd–4th born & 142 & 151 & 0.8 & 0.6–1.2 & 264 & 226 & 1.0 & 0.7–1.3 & 142 & 151 & 0.8 & 0.6–1.2 & 264 & 226 & 1.0 & 0.7–1.3 \\
\hline
≥5th born & 83 & 75 & 1.0 & 0.7–1.5 & 68 & 65 & 1.0 & 0.7–1.5 & 83 & 75 & 1.0 & 0.7–1.5 & 68 & 65 & 1.0 & 0.7–1.5 \\
\hline
Mean ± SD & 3.6 ± 2.7 & 3.3 ± 2.7 & & & 2.6 ± 1.9 & 2.6 ± 2.0 \\
\hline
Median & 2.0 & 3.3 & & & 2.0 & 2.0 \\
\hline
Range & 1–14 & 1–14 & & & 1–12 & 1–11 \\
\hline
Born ≥1948d,e & n = 129 & n = 134 & & & n = 233 & n = 181 & & & n = 101 & n = 109 & & & n = 164 & n = 115 \\
\hline
1st born (ref.) & 37 & 41 & Ref. & & 80 & 67 & Ref. & & 29 & 31 & Ref. & & 55 & 45 & Ref. \\
\hline
2nd–4th born & 56 & 61 & 1.0 & 0.5–1.7 & 138 & 97 & 1.2 & 0.8–1.9 & 46 & 50 & 0.7 & 0.4–1.5 & 98 & 59 & 1.0 & 0.6–1.8 \\
\hline
≥5th born & 36 & 32 & 1.2 & 0.6–2.3 & 15 & 17 & 0.7 & 0.3–1.6 & 26 & 28 & 0.7 & 0.3–1.6 & 11 & 11 & 0.5 & 0.2–1.5 \\
\hline
Mean ± SD & 3.6 ± 2.7) & 3.3 ± 2.6) & & & 2.3 ± 1.5) & 2.3 ± 1.6) \\
\hline
Median & 3.0 & 2.5 & & & 2.0 & 2.0 \\
\hline
Range & 1–14 & 1–14 & & & 1–10 & 1–11 \\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|}
\hline
LPA2 expression & Low (36) & High (48) & P \\
\hline
Age (years) \\
\hline
<50 & 20 (56%) & 16 (33%) & 0.042 \\
\hline
≥50 & 16 (44%) & 32 (67%) \\
\hline
Tumour size \\
\hline
(≤2.0 T1 cm) & 16 (44%) & 17 (35%) & NS \\
\hline
T2 (>2.0 cm to ≤5.0 cm) & 18 (50%) & 25 (52%) \\
\hline
T3 (>5.0 cm) & 2 (6%) & 6 (13%) \\
\hline
Nuclear grade \\
\hline
I & 5 (14%) & 5 (10%) & NS \\
\hline
II & 24 (67%) & 31 (65%) \\
\hline
III & 7 (19%) & 12 (25%) \\
\hline
Menopausal status \\
\hline
Premenopausal & 21 (58%) & 17 (35%) & 0.037 \\
\hline
Postmenopausal & 15 (42%) & 31 (65%) \\
\hline
Oestrogen receptor status \\
\hline
Negative & 10 (55%) & 27 (56%) & NS \\
\hline
Positive & 8 (45%) & 21 (44%) \\
\hline
Nodal metastasis \\
\hline
Negative & 12 (33%) & 21 (44%) & NS \\
\hline
Positive & 24 (67%) & 27 (56%) \\
\hline
Distant metastasis \\
\hline
Negative & 27 (75%) & 41 (85%) & NS \\
\hline
Positive & 9 (25%) & 7 (15%) \\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|}
\hline
Parameter & Total evaluations (%) & Evaluations in VAP group (%) \\
\hline
Number of evaluations & 219 (100%) & 38 (100%) \\
\hline
Tracheostomy (n [%]) & 59 (26.9%) & 10 (26.3%) \\
\hline
Atelectasisa (n [%]) & 13 (6.0%) & 6 (15.7%) \\
\hline
Lung edemaa (n [%]) & 35 (16.0%) & 9 (23.6%) \\
\hline
Lung contusiona (n [%]) & 6 (2.7%) & 1 (2.6%) \\
\hline
Pleural effusiona (n [%]) & 21 (9,5%) & 8 (21.0%) \\
\hline
Previous lung disease (n [%]) & 30 (13.6%) & 6 (15.7%) \\
\hline
COPD & 16 (7.3%) & 3 (7.8%) \\
\hline
Cancer & 11 (5.0%) & 2 (5.2%) \\
\hline
Asthma & 2 (0.9%) & 1 (2.6%) \\
\hline
Pulmonary fibrosis & 1 (0.4%) & None \\
\hline
Broncoaspiration (n [%]) & 12 (5.4%) & 3 (7.8%) \\
\hline
Sepsis (n [%]) & 46 (21.0%) & 14 (36.8%) \\
\hline
ARDS (n [%]) & 12 (5,4%) & 3 (7.8%) \\
\hline
(n Renal failure [%]; creatinine >2.0 mg/dl) & 91 (41.5%) & 20 (52.6%) \\
\hline
Diabetes (n [%]) & 35 (16.0%) & 5 (13.1%) \\
\hline
Chemotherapy (n [%]) & 13 (6.0%) & 2 (5.2%) \\
\hline
Radiotherapy (n [%]) & 2 (0.9%) & None \\
\hline
Immunossupressants drugs (n [%]) & 5 (2.2%) & 1 (2.6%) \\
\hline
AIDS (n [%]) & 3 (1.3%) & None \\
\hline
Renal transplantation (n [%]) & 5 (2.2%) & 1 (2.6%) \\
\hline
(n Abdominal surgery [%]) & 32 (14.6%) & 7 (18.4%) \\
\hline
Multiple trauma (n [%]) & 21 (9.5%) & 3 (7.9%) \\
\hline
Neuromuscular blocking agents (n [%]) & 7 (3.1%) & 7 (18.4%) \\
\hline
Central venous line (n [%]) & 215 (98.0%) & 38 (100%) \\
\hline
Intracranial pressure monitoring (n [%]) & 20 (9.1%) & 1 (2.6%) \\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|l|l|}
\hline
Type of toxicity & & \multicolumn{2}{c|}{No (n} & & & & \multicolumn{2}{c|}{Yes} & & & P* \\
\hline
& 0 & 1 & 2 & 3 & 4 & 0 & 1 & 2 & 3 & 4 \\
\hline
Anemia & 87 & 6 & 4 & 3 & 0 & 77 & 12 & 9 & 0 & 1.5 & 0.12 \\
\hline
Leukopenia & 58 & 15 & 22 & 3 & 3 & 36 & 11 & 23 & 20 & 11 & 0.0001 \\
\hline
Neutropenia & 82 & 8 & 6 & 2 & 2 & 50 & 12 & 11 & 17 & 11 & <0.0001 \\
\hline
Febrile Neutropenia & 100 & 0 & 0 & 0 & 0 & 95 & 0 & 0 & 5 & 0 & 0.05 \\
\hline
Infection & 96 & 0 & 2 & 2 & 0 & 95 & 0 & 2 & 3 & 0 & 0.89 \\
\hline
\multirow{2}{*}{Fever Thrombocytopenia} & \multirow{2}{*}{100 90} & \multirow{2}{*}{0 6} & \multirow{2}{*}{0 2} & \multirow{2}{*}{0 1} & \multirow{2}{*}{0 1} & \multirow{2}{*}{94 91} & \multirow{2}{*}{6 4.5} & \multirow{2}{*}{0 1.5} & \multirow{2}{*}{0 1.5} & \multirow{2}{*}{0 1.5} & \multirow{2}{*}{0.02 0.96} \\
\hline
\\
\hline
\\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|}
\hline
Adverse Event* & Mild & Moderate & Severe \\
\hline
\multirow{2}{*}{Bruising Inflammation} & \multirow{2}{*}{2 1} & \multirow{2}{*}{0 1} & \multirow{2}{*}{0 0} \\
\hline
\\
\hline
\multirow{2}{*}{Pain} & \multirow{2}{*}{3} & \multirow{2}{*}{6} & \multirow{2}{*}{1} \\
\hline
\\
\hline
\multirow{2}{*}{Site Reaction NOS} & \multirow{2}{*}{2} & \multirow{2}{*}{1} & \multirow{2}{*}{0} \\
\hline
\\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|l|}
\hline
Variable & Study Site n mean (SD) & 2001–03 % median (25%–75%) & STS (2001–03) % median (25%–75%) & P – value \\
\hline
Intra-aortic Balloon pump (any) & 73 & 14.5 & 9.2 & <.001 \\
\hline
Blood Transfusion (Any) & 256 & 50.8 & 45.3 & .014 \\
\hline
Complication \\
\hline
ReOp Bleeding & 14 & 2.78 & 2.50 & .798 \\
\hline
Perioperative myocardial infarction & 3 & 0.60 & 1.07 & .414 \\
\hline
Sternal wound infection & 1 & 0.20 & 0.47 & .578 \\
\hline
Leg wound infection & 14 & 2.78 & 0.70 & <.001 \\
\hline
Septicemia & 7 & 1.39 & 1.03 & .570 \\
\hline
\multirow{2}{*}{Urinary Infection Permanent Stroke} & \multirow{2}{*}{9 4} & \multirow{2}{*}{1.79 0.79} & \multirow{2}{*}{1.67 1.53} & \multirow{2}{*}{.973 .242} \\
\hline
\\
\hline
\multirow{2}{*}{Post-Op Ventilator (hours)} & \multirow{2}{*}{23.2 80.3} & \multirow{2}{*}{6.3 (4.0–15.8)} & \multirow{2}{*}{21.73} \\
\hline
\multirow{2}{*}{.012} \\
\hline
\multirow{2}{*}{Pneumonia} & \multirow{2}{*}{15} & \multirow{2}{*}{2.98} & \multirow{2}{*}{2.87} \\
\hline
\multirow{2}{*}{<.001} \\
\hline
\multirow{2}{*}{Atrial Fibrillation} & \multirow{2}{*}{144} & \multirow{2}{*}{28.6} & \multirow{2}{*}{19.9} \\
\hline
\\
\hline
Operative Mortality & 12 & 2.38 & 2.53 & .940 \\
\hline
Total LOS (days) & 8.59 6.11 & 7 (5–10) & 8.97 \\
\hline
Post-Op LOS (days) & 6.45 5.27 & 5 (4–7) & 6.87 \\
\hline
30-day Readmission & 59 & 11.7 & 8.4 & .009 \\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|l|}
\hline
Filter Dates & Period of collection (days) & Mass of PM10 collected (µg) onto filter & PM10 collected per 24 (µg) hours & Maximum PM10 dose (µg) instilled \\
\hline
\multirow{2}{*}{21/6–29/6 29/6–6/7} & \multirow{2}{*}{8 7} & \multirow{2}{*}{2893 2186} & \multirow{2}{*}{360 312} & \multirow{2}{*}{180 156} \\
\hline
\\
\hline
\multirow{2}{*}{26/7–3/8 1/9–7/9} & \multirow{2}{*}{8 6} & \multirow{2}{*}{3741 3071} & \multirow{2}{*}{466 510} & \multirow{2}{*}{233 255} \\
\hline
\\
\hline
\multirow{2}{*}{5/10–12/10 26/10–2/11} & \multirow{2}{*}{7 7} & \multirow{2}{*}{2011 1569} & \multirow{2}{*}{286 224} & \multirow{2}{*}{143 112} \\
\hline
\\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|}
\hline
& & Men & Women \\
\hline
\multicolumn{2}{c|}{Individual variable (20030 men and 21076 women)} \\
\hline
Age (mean, range: years) & & 42.9 (25–59) & 42.9 (25–59) \\
\hline
Marital status (N, %) & \multirow{2}{*}{Married Single} & \multirow{2}{*}{14701 (73.4) 4635 (23.1)} & \multirow{2}{*}{16208 (76.9) 3217 (15.3)} \\
\hline
\\
\hline
& \multirow{2}{*}{Divorced} & \multirow{2}{*}{557 (2.8)} & \multirow{2}{*}{1110 (5.3)} \\
\hline
\\
\hline
Occupation a (N, %) & \multirow{2}{*}{Profession Manager} & \multirow{2}{*}{3747 (18.7) 1736 (8.7)} & \multirow{2}{*}{2243 (10.6) 310 (1.5)} \\
\hline
\\
\hline
& \multirow{2}{*}{Sales work} & \multirow{2}{*}{1972 (9.8)} & \multirow{2}{*}{1785 (8.5)} \\
\hline
\\
\hline
& Service work & 1697 (8.5) & 2242 (10.6) \\
\hline
& Agriculture & 680 (3.4) & 535 (2.5) \\
\hline
& Transport & 1063 (5.3) & 80 (0.4) \\
\hline
& Labour & 4752 (23.7) & 2167 (10.3) \\
\hline
& Housework & 28 (0.1) & 5765 (27.4) \\
\hline
& Others & 2579 (12.9) & 2898 (13.8) \\
\hline
Income quintile (median: thousand yen) & 5th (highest) & \multicolumn{2}{c|}{6035} \\
\hline
& 4th & \multicolumn{2}{c|}{4000} \\
\hline
& \multirow{2}{*}{3rd 2nd} & \multirow{2}{*}{2989 2200} \\
\hline
\\
\hline
\multirow{2}{*}{Regional variable (60 prefectures and metropolitan} \\
\hline
\multirow{2}{*}{1423.4 (865–2042)} \\
\hline
\multirow{2}{*}{Unemployment rate (mean, range: %)} \\
\hline
\\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|}
\hline
Mass (m/z) & P \\
\hline
4504 & 0.0004 \\
\hline
11650 & 0.0003 \\
\hline
11691 & 0.0002 \\
\hline
14047 & 0.00001 \\
\hline
28107 & 0.000002 \\
\hline
28958 & 0.0000005 \\
\hline
39871 & 0.0004 \\
\hline
46175 & 0.0008 \\
\hline
60806 & 0.0002 \\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|}
\hline
Tumor type & & \multicolumn{2}{c|}{TACC3a} & & & \multicolumn{2}{c|}{TACC1a} & & TACC3 & TACC1b \\
\hline
& & Tumor & gradesc & & & Tumor & gradesc & & Tumor gradesc \\
\hline
& I & II & III & all & I & II & III & all & all \\
\hline
serous papillary & 1d (7)e 14.3%f & 6 (18) 33.3% & 2 (17) 11.8% & 9 (42) 21.4% & 6 (7) 85.7% & 13 (18) 72.2% & 11 (17) 64.7% & 30 (42) 71.4% & 6 (42) 14.3% \\
\hline
\multirow{2}{*}{mucinous endometroid} & \multirow{2}{*}{1 (3) 33.3% 3 (5) 60%} & \multirow{2}{*}{0 (1) 0% 0 (1) 0%} & \multirow{2}{*}{1 (1) 100% 0 (1) 0%} & \multirow{2}{*}{2 (5) 40% 3 (7) 42.8%} & \multirow{2}{*}{1 (3) 33.3% 2 (5) 40%} & \multirow{2}{*}{1 (1) 100% 0 (1) 0%} & \multirow{2}{*}{1 (1) 100% 0 (1) 0%} & \multirow{2}{*}{3 (5) 60% 2 (7) 28.6%} & \multirow{2}{*}{2 (5) 40% 1 (7) 14.3%} \\
\hline
\\
\hline
\multirow{2}{*}{clear cellg all types} & \multirow{2}{*}{5 (15) 33.3%} & \multirow{2}{*}{6 (20) 30.0%} & \multirow{2}{*}{7(11) 63.6% 10 (30) 33.3%} & \multirow{2}{*}{7 (11) 63.6% 21(65) 32.3%} & \multirow{2}{*}{9 (15) 60.0%} & \multirow{2}{*}{14 (20) 70.0%} & \multirow{2}{*}{6 (11) 54.5% 18 (30) 60.0%} & \multirow{2}{*}{6 (11) 54.5% 41 (65) 63.1%} & \multirow{2}{*}{5 (11) 45.5% 14 (65) 21.5%} \\
\hline
\\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|l|l|}
\hline
Exon & Codon Change & Nucleotide changea & Effectb & Change in amino acid/protein property & Remarks \\
\hline
3 & TCA>TTA & c.278C>T & Ser93Leu & Hydrophilic to hydrophobic & In proband (ovarian cancer), and mother (uterine cancer); not in two unaffected sisters. \\
\hline
4 & GAG> AAG & c.427G>A & Glu143Lys & Acidic to basic & Polymorphism \\
\hline
4 & AGC>AGT & c.531C>T & Ser177Ser & Silent & Polymorphism \\
\hline
\multirow{2}{*}{4 4} & \multirow{2}{*}{c.673_708del AAAGCGGAGACTCCGCACG GAGCCGAGGAAGAATGC GGC>GGG} & \multirow{2}{*}{Lys225_Cys236del Gly362Gly} & \multirow{2}{*}{Removal of one 12 amino acid repeat Silent} & \multirow{2}{*}{Polymorphism Polymorphism} \\
\hline
\\
\hline
& & & & change \\
\hline
5 & GCG>GTG & c.1406C>T & Ala469Val & & Polymorphism \\
\hline
\multirow{2}{*}{6 9} & \multirow{2}{*}{GGG>GAG TTC>TTT} & \multirow{2}{*}{c.1541G>A c.1809T>C} & \multirow{2}{*}{Gly514Glu Phe603Leu} & \multirow{2}{*}{Small hydrophobic to acidic Aromatic to aliphatic} & \multirow{2}{*}{Only in affected sibling, not in unaffected sister or daughter. Polymorphism} \\
\hline
\\
\hline
\multirow{2}{*}{16} & & \multirow{2}{*}{c.2621T>A} & & & \multirow{2}{*}{3' untranslated region. Polymorphism} \\
\hline
\\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|}
\hline
& Cure (%) & Improved (%) & Not Improved (%) \\
\hline
\multirow{2}{*}{AOM without Perforation (n = 14) AOM with Perforation (n = 12)} & \multirow{2}{*}{3 (21%) 3 (25%)} & \multirow{2}{*}{1 (7%) 1 (8%)} & \multirow{2}{*}{10 (71%) 8 (67%)} \\
\hline
\\
\hline
TOTAL (n = 26) & 6 (23%) & 2 (8%) & 18 (69%) \\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|l|l|}
\hline
Item No. & Item & Mean & SD & Item-Diff. Index & loading & \multicolumn{3}{c|}{Cronbach's} & \multicolumn{2}{c|}{rItem-total} & old Scale \\
\hline
& & & & & & \multirow{2}{*}{Total long} & Scale-wise & \multirow{2}{*}{long} & \multirow{2}{*}{short} \\
\hline
\\
\hline
\multirow{2}{*}{10*} & \multirow{2}{*}{Initiative Power & Interest good ideas} & \multirow{2}{*}{2.26} & \multirow{2}{*}{0.94} & \multirow{2}{*}{0.57} & \multirow{2}{*}{0.747} & \multirow{2}{*}{0.933} & \multirow{2}{*}{0.852} & \multirow{2}{*}{0.885 0.875} & \multirow{2}{*}{0.54} & \multirow{2}{*}{0.49} & \multirow{2}{*}{3} \\
\hline
\\
\hline
\multirow{2}{*}{11*} & \multirow{2}{*}{concerned} & \multirow{2}{*}{2.72} & \multirow{2}{*}{1.02} & \multirow{2}{*}{0.68} & \multirow{2}{*}{0.630} & \multirow{2}{*}{0.932} & \multirow{2}{*}{0.846} & \multirow{2}{*}{0.871} & \multirow{2}{*}{0.67} & \multirow{2}{*}{0.61} & \multirow{2}{*}{3} \\
\hline
\\
\hline
\\
\hline
12 & put plans into action & 2.09 & 0.91 & 0.52 & 0.572 & 0.933 & & 0.877 & 0.58 & & 4 \\
\hline
25 & difficult to take the initiative & 2.33 & 1.12 & 0.58 & 0.535 & 0.932 & & 0.873 & 0.65 & & 4 \\
\hline
36 & enhanced personally & 2.02 & 1.11 & 0.51 & 0.531 & 0.934 & & 0.881 & 0.47 & & 4 \\
\hline
34 & adapt to other people and situations & 2.79 & 0.81 & 0.70 & 0.530 & 0.934 & & 0.878 & 0.50 & & 3 \\
\hline
33 & asserted in the environment & 2.48 & 0.96 & 0.62 & 0.519 & 0.933 & & 0.876 & 0.55 & & 4 \\
\hline
17 & felt secure & 2.36 & 0.95 & 0.59 & 0.481 & 0.932 & & 0.874 & 0.66 & & 4 \\
\hline
21 & future was clear & 2.21 & 1.14 & 0.55 & 0.455 & 0.933 & & 0.879 & 0.56 & & 4 \\
\hline
06 & sought contact to others & 2.27 & 1.10 & 0.57 & 0.453 & 0.935 & & 0.884 & 0.41 & & \multirow{2}{*}{5 3} \\
\hline
30 & \multirow{2}{*}{felt enterprising/energetic Social Interaction} & 2.01 & 1.05 & 0.50 & 0.431 & 0.932 & & \multirow{2}{*}{0.876 0.812} & 0.66 \\
\hline
& & & & & & & & & \multirow{2}{*}{5} \\
\hline
\multirow{2}{*}{16* 27*} & \multirow{2}{*}{felt left out felt over-directed} & \multirow{2}{*}{2.79 2.90} & \multirow{2}{*}{1.07 1.10} & \multirow{2}{*}{0.70 0.73} & \multirow{2}{*}{0.697 0.636} & \multirow{2}{*}{0.933 0.933} & \multirow{2}{*}{0.850 0.853} & \multirow{2}{*}{0.775 0.780} & \multirow{2}{*}{0.57 0.57} & \multirow{2}{*}{0.52 0.51} \\
\hline
\multirow{2}{*}{5} \\
\hline
\multirow{2}{*}{18} & \multirow{2}{*}{family life was a burden} & \multirow{2}{*}{2.92} & \multirow{2}{*}{1.18} & \multirow{2}{*}{0.73} & \multirow{2}{*}{0.546} & \multirow{2}{*}{0.934} & & \multirow{2}{*}{0.792} & \multirow{2}{*}{0.52} \\
\hline
& & \multirow{2}{*}{5} \\
\hline
& others \\
\hline
28 & convey feelings to other & 2.63 & 0.92 & 0.66 & 0.496 & 0.933 & & 0.788 & 0.57 & & 5 \\
\hline
05 & anxious/fearful & 2.42 & 1.20 & 0.61 & 0.461 & 0.933 & & 0.797 & 0.56 & & 3 \\
\hline
& Mental Balance & & & & & & & 0.812 \\
\hline
35* & nervous / irascibly & 1.99 & 1.06 & 0.50 & 0.640 & 0.934 & 0.858 & 0.803 & 0.47 & 0.40 & 3 \\
\hline
26* & well-balanced & 2.01 & 0.97 & 0.50 & 0.600 & 0.932 & 0.850 & 0.770 & 0.67 & 0.61 & \multirow{2}{*}{3 2} \\
\hline
19* & exhausted & 1.24 & 0.94 & 0.31 & 0.567 & 0.933 & 0.849 & 0.782 & 0.59 & 0.56 \\
\hline
\multirow{2}{*}{09 31} & \multirow{2}{*}{could recover myself tired} & \multirow{2}{*}{1.57 1.38} & \multirow{2}{*}{0.99 0.92} & \multirow{2}{*}{0.39 0.35} & \multirow{2}{*}{0.557 0.554} & \multirow{2}{*}{0.933 0.933} & & \multirow{2}{*}{0.784 0.784} & \multirow{2}{*}{0.55 0.57} & & \multirow{2}{*}{2} \\
\hline
\\
\hline
\multirow{2}{*}{04} & \multirow{2}{*}{sleep was refreshing} & \multirow{2}{*}{1.55} & \multirow{2}{*}{1.05} & \multirow{2}{*}{0.39} & \multirow{2}{*}{0.356} & \multirow{2}{*}{0.935} & & \multirow{2}{*}{0.809} & \multirow{2}{*}{0.42} & & \multirow{2}{*}{2} \\
\hline
\\
\hline
\multirow{2}{*}{22*} & \multirow{2}{*}{physically agile} & \multirow{2}{*}{1.95} & \multirow{2}{*}{1.02} & \multirow{2}{*}{0.49} & \multirow{2}{*}{0.789} & \multirow{2}{*}{0.935} & \multirow{2}{*}{0.854} & \multirow{2}{*}{0.708} & \multirow{2}{*}{0.40} & \multirow{2}{*}{0.43} & \multirow{2}{*}{1} \\
\hline
\\
\hline
\multirow{2}{*}{38*} & \multirow{2}{*}{arms and legs felt heavy} & \multirow{2}{*}{1.36} & \multirow{2}{*}{1.07} & \multirow{2}{*}{0.34} & \multirow{2}{*}{0.668} & \multirow{2}{*}{0.935} & \multirow{2}{*}{0.855} & \multirow{2}{*}{0.571} & \multirow{2}{*}{0.39} & \multirow{2}{*}{0.42} & \multirow{2}{*}{1} \\
\hline
\\
\hline
37 & powerful & 1.47 & 0.95 & 0.37 & 0.509 & 0.933 & & 0.482 & 0.56 & & 2 \\
\hline
& Physical Complaints & & & & & & & 0.692 \\
\hline
02* & suffered from physical pain & 1.04 & 0.97 & 0.26 & 0.726 & 0.936 & 0.859 & * & 0.27 & 0.32 & 1 \\
\hline
01* & felt ill & 1.09 & 0.91 & 0.27 & 0.705 & 0.935 & 0.853 & * & 0.42 & 0.44 & 2 \\
\hline
& Digestive Well-Being & & & & & & & 0.621 \\
\hline
03* & good appetite & 2.71 & 1.12 & 0.68 & 0.763 & 0.935 & 0.857 & * & 0.37 & 0.38 & 2 \\
\hline
23* & mealtimes were a burden & 2.87 & 1.10 & 0.72 & 0.734 & 0.934 & 0.853 & * & 0.45 & 0.46 & 2 \\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|l|l|l|}
\hline
Protein & CC2102 [16126341] & CC3292 [16127522] & CC3319b [16127549] & CC1887c [16126130] & CC1725 [16125969] & CC1365 [16125614] \\
\hline
Length & 162 & 224 & 89 & 105 & 100 & 161 \\
\hline
Mag. mag. & 2e-19 (1.04) & 9e-49 (1.29) & 2e-15 (0.99) & 3e-20 (1.10) & 1e-08 (0.88) & 2e-21 (0.87) \\
\hline
Rhod. rubr. & 3e-17 (1.09) & 1e-42 (0.92) & 1e-12 (1.04) & 4e-21 (1.12) & 1e-08 (1.09) & 3e-17 (0.96) \\
\hline
Nov. aro. & 1e-19 (1.02) & 3e-45 (1.04) & 4e-07 (0.88) & 2e-25 (1.30) & - & 1e-11 (0.98) \\
\hline
Z. mobilis * & 4e-24 (1.01) & 6e-40 (1.00) & - & - & - & 5e-11 (1.02) \\
\hline
C. cres.* & 1e-64 (1.00) & e-106 (1.00) & 1e-34 (1.00) & 3e-61 (1.00) & 4e-49 (1.00) & 7e-79 (1.00) \\
\hline
\multirow{2}{*}{Sil. pom.* Sil. sp.} & \multirow{2}{*}{3e-16 (0.93) 1e-13 (0.98)} & \multirow{2}{*}{2e-44 (1.15) 1e-43 (1.14)} & \multirow{2}{*}{8e-11 (0.97) 8e-09 (0.99)} & \multirow{2}{*}{3e-22 (1.21) 5e-24 (1.22)} & \multirow{2}{*}{8e-06 (0.99) 1e-05 (0.88)} & \multirow{2}{*}{4e-12 (0.96) 9e-12 (0.89)} \\
\hline
\\
\hline
\multirow{2}{*}{Bra. jap.*} & \multirow{2}{*}{5e-21 (1.06)} & \multirow{2}{*}{8e-47 (1.11)} & \multirow{2}{*}{2e-12 (1.01)} & \multirow{2}{*}{2e-29 (1.29)} & \multirow{2}{*}{2e-09 (1.05)} & \multirow{2}{*}{2e-11 (1.15)} \\
\hline
\\
\hline
\multirow{2}{*}{Agr. tum.*} & \multirow{2}{*}{4e-21 (1.04)} & \multirow{2}{*}{7e-49 (1.02)} & \multirow{2}{*}{4e-10 (0.96)} & \multirow{2}{*}{3e-26 (1.26)} & \multirow{2}{*}{5e-06 (1.14)} & \multirow{2}{*}{7e-13 (1.10)} \\
\hline
\\
\hline
\multirow{2}{*}{Bru. mel.*} & \multirow{2}{*}{5e-19 (1.17)} & \multirow{2}{*}{4e-48 (1.02)} & \multirow{2}{*}{1e-12 (1.03)} & \multirow{2}{*}{1e-23 (1.30)} & \multirow{2}{*}{1e-07 (1.09)} & \multirow{2}{*}{4e-15 (1.04)} \\
\hline
\\
\hline
Bru. suis* & 5e-19 (1.17) & 4e-48 (1.02) & 2e-12 (0.97) & 1e-23 (1.30) & 2e-08 (1.09) & 4e-15 (1.07) \\
\hline
Meso. loti* & 5e-18 (1.10) & 9e-49 (1.00) & 9e-18 (0.97) & 9e-23 (1.26) & 4e-09 (1.20) & 3e-14 (1.40) \\
\hline
Meso. sp. & 2e-17 (1.09) & 2e-47 (1.03) & 5e-16 (0.98) & 6e-27 (1.26) & 8e-06 (1.05) & 7e-15 (1.33) \\
\hline
B. henselae* & 8e-14 (1.12) & 5e-41 (1.04) & 4e-12 (0.96) & 2e-23 (1.26) & 5e-08 (1.09) & 4e-10 (0.99) \\
\hline
B. Quintana* & 5e-14 (1.12) & 8e-42 (1.02) & 4e-12 (0.96) & 5e-21 (1.26) & 1e-08 (1.09) & 3e-11 (0.99) \\
\hline
R. conorii* & 5e-10 (0.97) & 3e-41 (0.83) & 1e-07 (0.88) & 1e-05 (0.94) & 5e-11 (1.01) & 7e-07 (0.98) \\
\hline
R. prowazekii* & 4e-08 (0.98) & 4e-40 (0.83) & 3e-07 (0.88) & 5e-07 (0.95) & 2e-12 (1.07) & 8e-06 (0.95) \\
\hline
R. typhi* & 1e-08 (0.98) & 2e-40 (0.83) & 3e-07 (0.88) & 4e-07 (0.95) & 5e-11 (1.07) & 3e-06 (0.98) \\
\hline
R. akari & 6e-09 (0.97) & 9e-41 (0.90) & 1e-07 (0.88) & 2e-05 (0.94) & 7e-12 (1.07) & 3e-07 (0.98) \\
\hline
R. rickettsii & 1e-10 (0.97) & 9e-41 (0.83) & 1e-07 (0.88) & 1e-05 (0.94) & 5e-11 (1.01) & 7e-07 (0.98) \\
\hline
\multirow{2}{*}{R. sibirica Wolbachia*} & \multirow{2}{*}{2e-10 (0.97) 5e-11 (0.90)} & \multirow{2}{*}{5e-41 (0.83) 3e-20 (0.89)} & \multirow{2}{*}{1e-07 (0.88) 2e-07 (0.99)} & \multirow{2}{*}{1e-05 (0.94) 1e-08 (0.99)} & \multirow{2}{*}{5e-11 (1.01) 1e-05 (1.04)} & \multirow{2}{*}{3e-07 (0.98) 3e-04 (0.70)} \\
\hline
\\
\hline
\multirow{2}{*}{Ehr. canis} & \multirow{2}{*}{2e-07 (1.01)} & \multirow{2}{*}{6e-39 (0.95)} & \multirow{2}{*}{2e-06 (1.04)} & \multirow{2}{*}{5e-10 (0.94)} & \multirow{2}{*}{-} & \multirow{2}{*}{0.023 (0.90)} \\
\hline
\\
\hline
\multirow{2}{*}{Non-Alpha} & \multirow{2}{*}{-} & \multirow{2}{*}{Strep. glau. 1.6} & \multirow{2}{*}{Fuso. nucl. 2.9} & \multirow{2}{*}{Burk. fung. (3.69)} & \multirow{2}{*}{Azo. sp. 0.44 (0.91)} & \multirow{2}{*}{Myc. pneum. 0.98} \\
\hline
\\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|}
\hline
Purpose type & Definition \\
\hline
\multirow{2}{*}{Etiology Prognosis} & \multirow{2}{*}{Content pertained directly to determining if there was an association between an exposure and a disease or condition. The question is "What causes people to get a disease or condition?" Content pertains directly to the prediction of the clinical course or the natural history of a disease or condition} \\
\hline
\\
\hline
Diagnosis & Content pertains directly to using a tool to arrive at a diagnosis of a disease or condition. \\
\hline
Treatment & Content pertains directly to an intervention for therapy (including adverse effects studies), prevention, rehabilitation, quality improvement, or continuing medical education. \\
\hline
\multirow{2}{*}{Cost Economics} & \multirow{2}{*}{Content pertains directly to the costs or financing or economics of a health care issue. Content pertains directly to the economics of a health care issue.} \\
\hline
\\
\hline
\multirow{2}{*}{Qualitative} & \multirow{2}{*}{Content relates to how people feel or experience certain situations, and data collection methods and analyses are} \\
\hline
\\
\hline
Something Else & Content of the study does not fit any of the above definitions. \\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|l|l|l|l|}
\hline
Analysis & Latency (yrs) & Spana & Cases/ Controls & S-Plus p-valuec & Deviance p- valuec & Kelsall/ Diggle p-valuec & Figure # \\
\hline
Adjusted All Residences & 0 & 0.95 & 385/ 1927 & 0.056 & 0.072 & 0.080 & 7a \\
\hline
Crude All Residences & 15 & 0.30 & 182/ 871 & 0.005 & 0.016 & 0.101 & 7c \\
\hline
\multirow{2}{*}{Adjusted All Residences Adjusted} & \multirow{2}{*}{15 15} & \multirow{2}{*}{0.30 0.30b} & \multirow{2}{*}{182/ 871 100/ 485} & \multirow{2}{*}{0.004 ---d} & \multirow{2}{*}{0.004 ---d} & \multirow{2}{*}{0.029 ---d} & \multirow{2}{*}{7b,d 7e} \\
\hline
\\
\hline
Adjusted Longest Duration & 15 & 0.95 & 100/ 485 & 0.227 & 0.351 & 0.381 & 7f \\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|}
\hline
& Diabetic subjects & Non-diabetic subjects & P-value \\
\hline
number/females & 49/26 & 49/26 \\
\hline
\multirow{2}{*}{attributes at screening age (years)} & \multirow{2}{*}{40.3 ± 1.8} & \multirow{2}{*}{40.4 ± 1.8} & \multirow{2}{*}{NS (0.96)} \\
\hline
\\
\hline
\multirow{2}{*}{current smokers (%)} & \multirow{2}{*}{18.4} & \multirow{2}{*}{10.2} & \multirow{2}{*}{NS (0.25)} \\
\hline
\\
\hline
\multirow{2}{*}{antihypertensive treatment (%)} & \multirow{2}{*}{16.3} & \multirow{2}{*}{8.2} & \multirow{2}{*}{NS (0.22)} \\
\hline
\\
\hline
\multirow{2}{*}{waist circumference (cm)} & \multirow{2}{*}{101 ± 1.4} & \multirow{2}{*}{99.8 ± 1.5} & \multirow{2}{*}{NS (0.63)} \\
\hline
\\
\hline
\\
\hline
plasma triglycerides (mmol/L) & 2.25 ± 0.14 & 1.53 ± 0.11 & <0.0001 \\
\hline
plasma glucose (mmol/L) & 10.79 ± 0.63 & 5.53 ± 0.07 & <0.0001 \\
\hline
serum insulin (pmol/L) & 157 ± 12 & 133 ± 9 & NS (0.16) \\
\hline
\multirow{2}{*}{time elapsed since screening (years) (µm)} & 7.34 ± 0.10 & 7.33 ± 0.10 & NS (0.96) \\
\hline
795 ± 19 & 789 ± 26 & NS (0.49) \\
\hline
mean TPV (mm3) & 109.9 ± 23.0 & 64.0 ± 17.0 & 0.037 \\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|l|l|}
\hline
Scan view & Myocardial segment & N & End-systolic analysis & End-diastolic analysis & All frames analysis \\
\hline
Apical Four-Chamber & \multirow{2}{*}{Basal septum Mid septum} & \multirow{2}{*}{20 20} & \multirow{2}{*}{0.41 ± 0.11 0.36 ± 0.12} & \multirow{2}{*}{0.63 ± 0.14 0.46 ± 0.15} & \multirow{2}{*}{0.56 ± 0.17 0.47 ± 0.16} \\
\hline
\\
\hline
& \multirow{2}{*}{Apical lateral} & \multirow{2}{*}{18} & \multirow{2}{*}{0.29 ± 0.10} & \multirow{2}{*}{0.43 ± 0.18} & \multirow{2}{*}{0.30 ± 0.12} \\
\hline
\\
\hline
& \multirow{2}{*}{Basal lateral} & \multirow{2}{*}{9} & \multirow{2}{*}{0.32 ± 0.13} & \multirow{2}{*}{0.55 ± 0.12} & \multirow{2}{*}{0.37 ± 0.14} \\
\hline
\\
\hline
Apical Two-chamber & \multirow{2}{*}{Basal inferior Mid inferior} & \multirow{2}{*}{14 15} & \multirow{2}{*}{0.43 ± 0.17 0.36 ± 0.09} & \multirow{2}{*}{0.59 ± 0.19 0.54 ± 0.11} & \multirow{2}{*}{0.44 ± 0.12 0.46 ± 0.15} \\
\hline
\\
\hline
& \multirow{2}{*}{Apical anterior} & \multirow{2}{*}{6} & \multirow{2}{*}{0.34 ± 0.10} & \multirow{2}{*}{0.45 ± 0.15} & \multirow{2}{*}{0.60 ± 0.29} \\
\hline
\\
\hline
\\
\hline
& Basal anterior & 6 & 0.24 ± 0.21 & 0.39 ± 0.11 & 0.35 ± 0.22 \\
\hline
Apical Long-axis & Basal inferolat. & 7 & 0.42 ± 0.14 & 0.69 ± 0.12 & 0.61 ± 0.17 \\
\hline
& Mid inferolat. & 11 & 0.36 ± 0.15 & 0.52 ± 0.16 & 0.40 ± 0.18 \\
\hline
& Apical inferolat. & 13 & 0.31 ± 0.13 & 0.42 ± 0.18 & 0.44 ± 0.16 \\
\hline
& Apical anterosept. & 18 & 0.31 ± 0.11 & 0.48 ± 0.23 & 0.33 ± 0.15 \\
\hline
& Mid anterosept. & 15 & 0.36 ± 0.15 & 0.41 ± 0.19 & 0.47 ± 0.11 \\
\hline
& Basal anterosept. & 12 & 0.45 ± 0.19 & 0.58 ± 0.20 & 0.48 ± 0.16 \\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|l|}
\hline
Group & Intercept & Slope & R2 & SEE \\
\hline
Cotton Gym Shorts & 3.52* & 1.01 & 0.97 & 1.29 \\
\hline
\multirow{2}{*}{Spandex Bicycle Males} & 1.24* & 1.02 & 0.96 & 1.40 \\
\hline
\multirow{2}{*}{3.73*} & \multirow{2}{*}{0.96} & \multirow{2}{*}{0.97} & \multirow{2}{*}{1.09} \\
\hline
\multirow{2}{*}{Spandex Bicycle} \\
\hline
\\
\hline
\multirow{2}{*}{Cotton Gym Shorts} & \multirow{2}{*}{5.20*} & \multirow{2}{*}{0.95} & \multirow{2}{*}{0.95} & \multirow{2}{*}{1.21} \\
\hline
\\
\hline
\\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|l|l|l|}
\hline
\multirow{2}{*}{CHLOROQUINE SYRUP Code} & & \multirow{2}{*}{DQCL-Sana'a} & \multirow{2}{*}{DQCL-Aden} \\
\hline
\\
\hline
& Assay (%) & % RSD & Assay (%) & % RSD & Assay (%) & % RSD \\
\hline
CQS/RMS & 104.1 & 3.20 & 96.20 & 0.60 & 102.0 & 0.36 \\
\hline
CQS/SMS & 105.7 & 1.10 & 100.5 & 1.01 & 100.5 & 3.71 \\
\hline
CQS/LGH & 109.0 & 3.20 & 99.4 & 1.94 & 101.2 & 1.77 \\
\hline
\multirow{2}{*}{CQS/MRH-1 CQS/HRH} & 91.1 & 3.50 & 101.2 & 2.65 & 102.7 & 3.80 \\
\hline
\multirow{2}{*}{100.0 116.2} & \multirow{2}{*}{0.85 3.00} & \multirow{2}{*}{95.3 98.5} & \multirow{2}{*}{0.65 1.22} & \multirow{2}{*}{107.7 99.4} & \multirow{2}{*}{0.71 0.75} \\
\hline
\multirow{2}{*}{CQS/HU-1} \\
\hline
\multirow{2}{*}{107.8} & \multirow{2}{*}{4.60} & \multirow{2}{*}{98.5} & \multirow{2}{*}{0.3} & \multirow{2}{*}{97.6} & \multirow{2}{*}{6.33} \\
\hline
\multirow{2}{*}{CQS/HU-8} \\
\hline
\multirow{2}{*}{109.9} & \multirow{2}{*}{1.20} & \multirow{2}{*}{98.1} & \multirow{2}{*}{0.83} & \multirow{2}{*}{95.9} & \multirow{2}{*}{9.15} \\
\hline
\multirow{2}{*}{CQS/PP-1} \\
\hline
\multirow{2}{*}{90.7} & \multirow{2}{*}{2.50} & \multirow{2}{*}{102.6} & \multirow{2}{*}{2.10} & \multirow{2}{*}{96.4} & \multirow{2}{*}{2.10} \\
\hline
\\
\hline
CQS/PP-3 & 107.0 & 4.90 & 97.5 & 3.10 & 100.7 & 2.8 \\
\hline
CQS/PP-4 & 98.0 & 4.30 & 101.3 & 2.10 & 99.7 & 1.45 \\
\hline
CQS/PP-5 & 100.3 & 4.60 & 101.6 & 1.14 & 102.4 & 1.36 \\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|l|l|l|l|l|}
\hline
Mf/ml & \multicolumn{2}{c|}{2001 No.} & \multicolumn{2}{c|}{2002 No.} & \multicolumn{2}{c|}{2003 No.} & \multicolumn{2}{c|}{2004 No.} \\
\hline
& Examined* & Treated** & Examined* & Treated** & Examined* & Treated** & Examined* & Treated** \\
\hline
0 & 429 (73.2) & 0 & 634 (82.4) & 126 (19.9) & 721 (93.9) & 482 (66.9) & 677 (96.2) & 548 (80.9) \\
\hline
1–100 & 66 (11.3) & 0 & 90 (11.7) & 22 (24.4) & 25 (3.3) & 17 (68.0) & 20 (2.8) & 14 (70.0) \\
\hline
101–500 & 42 (7.2) & 0 & 29 (3.8) & 6 (20.7) & 14 (1.8) & 6 (42.9) & 4 (0.6) & 2 (50.0) \\
\hline
>500 & 49 (8.3) & 0 & 16 (2.1) & 1 (6.3) & 8 (1.0) & 4 (50.0) & 3 (0.4) & 0 (0) \\
\hline
Total & 586 (100) & 0 & 769 (100) & 155 (20.5) & 768 (100) & 509 (66.3) & 704 (100) & 564 (80.1) \\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|l|}
\hline
Geographic Accessibility & Bulk-billing rate & Index of disadvantage† & GP density‡ & WPEs per head of population¶ \\
\hline
\multirow{2}{*}{1. 230} & \multirow{2}{*}{59%} & \multirow{2}{*}{Accessible* 6.8} & \multirow{2}{*}{0.96} & \multirow{2}{*}{0.82} \\
\hline
\\
\hline
\multirow{2}{*}{3. 413} & \multirow{2}{*}{81%} & \multirow{2}{*}{4.5} & \multirow{2}{*}{1.06} & \multirow{2}{*}{0.85} \\
\hline
\\
\hline
\multirow{2}{*}{5. 609} & \multirow{2}{*}{47%} & \multirow{2}{*}{5.3} & \multirow{2}{*}{0.89} & \multirow{2}{*}{0.80} \\
\hline
\\
\hline
& & Moderately Accessible* \\
\hline
6. 231 & 56% & 7.2 & 0.90 & 0.78 \\
\hline
7. 411 & 51% & 5.6 & 0.96 & 0.79 \\
\hline
8. 509 & 21% & 7.7 & 1.26 & 0.84 \\
\hline
9. 511 & 69% & 7.1 & 0.84 & 0.86 \\
\hline
10. 801 & 62% & 5.8 & 1.07 & 0.67 \\
\hline
& & Remote* \\
\hline
11. 241 & 76% & 9.1 & 0.69 & 0.76 \\
\hline
12. 416 & 64% & 7.3 & 0.54 & 0.65 \\
\hline
\multirow{2}{*}{13. 417 14. 512} & \multirow{2}{*}{64% 72%} & \multirow{2}{*}{7.9 7.8} & \multirow{2}{*}{0.73 0.90} & \multirow{2}{*}{0.71 0.74} \\
\hline
\\
\hline
\multirow{2}{*}{16. 612} & \multirow{2}{*}{58%} & \multirow{2}{*}{7.0} & \multirow{2}{*}{0.78} & \multirow{2}{*}{0.63} \\
\hline
\\
\hline
\multirow{2}{*}{17. 233} & \multirow{2}{*}{93%} & \multirow{2}{*}{8.9} & \multirow{2}{*}{0.71} & \multirow{2}{*}{0.70} \\
\hline
\\
\hline
\multirow{2}{*}{19. 610} & \multirow{2}{*}{93%} & \multirow{2}{*}{8.0} & \multirow{2}{*}{1.06} & \multirow{2}{*}{0.38} \\
\hline
\\
\hline
\\
\hline
21. 802 & 65% & 6.8 & 0.89 & 0.51 \\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|l|l|}
\hline
& Suicide later % & Suicide within a week from discharge % & All % & \multicolumn{2}{c|}{Age- and sex adjusted} \\
\hline
& N = 6689 & N = 1407 & N = 8096 & Exp(B) & 95,0% C.I. \\
\hline
\multirow{2}{*}{Age, y * Male} & \multirow{2}{*}{41.5 70.4} & \multirow{2}{*}{43.6 63.3} & \multirow{2}{*}{69.2} & \multirow{2}{*}{ref} \\
\hline
\multirow{2}{*}{2.10 – 2.58} \\
\hline
\multirow{2}{*}{Marital status *} \\
\hline
\multirow{2}{*}{43.2} & \multirow{2}{*}{47.1} & \multirow{2}{*}{43.9} & \multirow{2}{*}{1.29} & \multirow{2}{*}{1.12–1.49} \\
\hline
\multirow{2}{*}{Widow} \\
\hline
\multirow{2}{*}{1.0} & \multirow{2}{*}{0.7} & \multirow{2}{*}{0.9} & \multirow{2}{*}{1.08} & \multirow{2}{*}{0.56–2.06} \\
\hline
\\
\hline
Divorced & 23.6 & 16.3 & 22.4 & 1.00 & 0.85 – 1.18 \\
\hline
Married & 26.8 & 30.1 & 27.3 & ref \\
\hline
Education * \\
\hline
High grade & 12.5 & 16.9 & 13.3 & 1.57 & 1.34–1.83 \\
\hline
Middle grade & 36.5 & 34.5 & 36.2 & 1.07 & 0.94 – 1.21 \\
\hline
Low grade & 50.9 & 48.6 & 50.5 & ref \\
\hline
Socioeconomic status * & & & & \multirow{2}{*}{1.78} & \multirow{2}{*}{1.37 – 2.33} \\
\hline
Upper employee & 4.1 & 5.8 & 4.4 \\
\hline
Lower employee & 8.8 & 11.9 & 9.3 \\
\hline
\multirow{2}{*}{Entrepreneur Worker} & \multirow{2}{*}{17.0 4.9} & \multirow{2}{*}{15.4 5.5} & \multirow{2}{*}{16.7 5.0} & \multirow{2}{*}{1.25 0.91} & \multirow{2}{*}{0.95 – 1.63 0.75 – 1.10} \\
\hline
\\
\hline
\multirow{2}{*}{Retired} & \multirow{2}{*}{37.5} & \multirow{2}{*}{38.6} & \multirow{2}{*}{37.7} & \multirow{2}{*}{2.54} & \multirow{2}{*}{2.11 – 3.06} \\
\hline
\\
\hline
\multirow{2}{*}{Suicide method *} \\
\hline
\multirow{2}{*}{33.7} & \multirow{2}{*}{17.3} & \multirow{2}{*}{30.9} & \multirow{2}{*}{0.89} & \multirow{2}{*}{0.73 – 1.08} \\
\hline
\\
\hline
Hanging or other suffocation & 27.5 & 34.3 & 28.7 & 1.44 & 1.21 – 1.71 \\
\hline
Drowning & 6.6 & 16.4 & 8.3 & 3.38 & 2.75 – 4.16 \\
\hline
Shooting or exploding & 10.2 & 6.6 & 9.6 & 0.40 & 0.31 – 0.51 \\
\hline
Jumping from heights & 5.4 & 11.2 & 6.4 & 3.29 & 2.63 – 4.10 \\
\hline
Other & 16.6 & 14.2 & 16.2 & ref \\
\hline
Discharge diagnosis * \\
\hline
Substance-related disorders & 19.2 & 3.7 & 16.5 & 0.3 & 0.22 – 0.47 \\
\hline
Schizophrenia and similar psychoses & 25.4 & 37.2 & 27.4 & \multirow{2}{*}{2.3 2.3} & \multirow{2}{*}{1.67 – 3.07 1.68 – 3.08} \\
\hline
Affective disorders & 33.1 & 45.6 & 35.2 \\
\hline
\multirow{2}{*}{Neurotic-, stress-related and somatoform disorders Personality disorders} & \multirow{2}{*}{7.3 9.2} & \multirow{2}{*}{4.1 5.7} & \multirow{2}{*}{6.7 8.6} & \multirow{2}{*}{0.9 0.9} & \multirow{2}{*}{0.58 – 1.28 0.63 – 1.33} \\
\hline
\\
\hline
\\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|}
\hline
#of top genes & \multicolumn{2}{c|}{Minnesota data} \\
\hline
& All patients & Male \\
\hline
\multirow{2}{*}{50 100} & \multirow{2}{*}{18 13} & \multirow{2}{*}{16 18} \\
\hline
\\
\hline
\multirow{2}{*}{400} & \multirow{2}{*}{17} & \multirow{2}{*}{17} \\
\hline
\\
\hline
800 & 18 & 14 \\
\hline
1600 & 17 & 16 \\
\hline
3200 & 16 & 14 \\
\hline
6400 & 15 & 15 \\
\hline
9600 & 17 & 15 \\
\hline
12800 & 17 & 14 \\
\hline
16000 & 19 & 14 \\
\hline
19200 & 14 & 16 \\
\hline
22283 & 19 & 16 \\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|l|l|}
\hline
Study & Population & "N" (573) & Subjects/Notes & Controls & Av LLI (SD) \\
\hline
\multirow{2}{*}{Gross R. 1983 Venn et al 1983} & \multirow{2}{*}{Male marathon runners, age 24– 49 Randomly chosen patients} & \multirow{2}{*}{33 60} & No deleterious effect of the LLI & & \multirow{2}{*}{4.9 mm (3.8) 5.4 mm (4.0)} \\
\hline
\multirow{2}{*}{Standing and supine x-ray} \\
\hline
\multirow{2}{*}{Hoikka et al 1989} & \multirow{2}{*}{Chronic low back pain patients} & \multirow{2}{*}{100} & & \multirow{2}{*}{4.9 mm (3.6)} \\
\hline
\multirow{2}{*}{10 with history of LLI or lower} & \multirow{2}{*}{9 healthy} \\
\hline
\\
\hline
Soukka et al 1991 & Four defined occupational and gender groups, age 35–54 & 247 & 194 with prior back pain (>12 mo ago and during last 12 mo with and without disability) & 53 who never had back pain & 5.0 mm (3.9) \\
\hline
Rhodes et al 1995 & New LBP patients Chiropractic practice & 50 & Age 18–40 26 men 24 women & & 6.3 mm (4.1) \\
\hline
Mincer et al 1997 & Volunteers & 54 & no history of back pain in last 6 months 10 men 44 women & & 2.4 mm (1.8) \\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|l|l|l|l|}
\hline
& & \multicolumn{2}{c|}{Mean (SE) adjusted race-ethnicity} & & \multicolumn{2}{c|}{Mean (SE) adjusted ethnicity,} \\
\hline
Dependent variable, units & Discordant survey sample (N) & LAP quartile > BMI quartile & BMI quartile > LAP quartile & P value & LAP quartile > BMI quartile & BMI quartile > LAP quartile & P value \\
\hline
Total cholesterol, mmol/L & 4598 & 5.62 (0.04) & 4.89 (0.04) & <0.0001 & 5.50 (0.04) & 5.00 (0.04) & <0.0001 \\
\hline
HDL cholesterol, mmol/L & 4578 & 1.24 (0.01) & 1.37 (0.01) & <0.0001 & 1.22 (0.01) & 1.39 (0.01) & <0.0001 \\
\hline
LDL cholesterol, mmol/L & 3333 & 3.50 (0.04) & 3.11 (0.05) & <0.0001 & 3.40 (0.04) & 3.20 (0.05) & 0.0003 \\
\hline
Total cholesterol / HDL cholest. & 4577 & 4.93 (0.06) & 3.78 (0.05) & <0.0001 & 4.88 (0.06) & 3.82 (0.05) & <0.0001 \\
\hline
Apolipoprotein B, g/L & 2245* & 1.13 (0.01) & 0.94 (0.01) & <0.0001 & 1.10 (0.01) & 0.97 (0.01) & <0.0001 \\
\hline
\multirow{2}{*}{ApoB/ApoA1 LDL cholesterol /ApoB, mmol/g} & \multirow{2}{*}{2230* 1614*} & \multirow{2}{*}{0.809 (0.012) 3.06 (0.04)} & \multirow{2}{*}{0.681 (0.010) 3.26 (0.03)} & \multirow{2}{*}{<0.0001 0.0007} & \multirow{2}{*}{0.799 (0.013) 3.03 (0.04)} & \multirow{2}{*}{0.690 (0.010) 3.29 (0.03)} & \multirow{2}{*}{<0.0001 <0.0001} \\
\hline
\\
\hline
\multirow{2}{*}{Systolic blood pressure, mmHg} & \multirow{2}{*}{4595} & \multirow{2}{*}{124.9 (0.7)} & \multirow{2}{*}{118.3 (0.4)} & \multirow{2}{*}{<0.0001} & \multirow{2}{*}{121.3 (0.6)} & \multirow{2}{*}{121.6 (0.4)} & \multirow{2}{*}{0.62} \\
\hline
\\
\hline
\multirow{2}{*}{Heart rate, bpm} & \multirow{2}{*}{4494} & \multirow{2}{*}{75.0 (0.5)} & \multirow{2}{*}{72.4 (0.6)} & \multirow{2}{*}{0.0005} & \multirow{2}{*}{75.1 (0.5)} & \multirow{2}{*}{72.3 (0.6)} & \multirow{2}{*}{0.0001} \\
\hline
\\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|l|}
\hline
gDNA Input (ng) & Completed Genotypes1 & % Completion & Undeter. Genotypes & % Undeter. & No Amp. & % No Amp. & Concordant Genotypes & % Concordance & Discordant Genotypes & % Discordance \\
\hline
& & & \multicolumn{2}{c|}{1 ng gDNA or} & \multicolumn{2}{c|}{into TaqMan®} & assay2,3 \\
\hline
\multirow{2}{*}{gDNA 1} & \multirow{2}{*}{2636 25524} & \multirow{2}{*}{99.62 96.45} & \multirow{2}{*}{10 945} & \multirow{2}{*}{0.38 3.55} & \multirow{2}{*}{0 0} & \multirow{2}{*}{0 0} & \multirow{2}{*}{2636 2546} & \multirow{2}{*}{100.00 99.76} & \multirow{2}{*}{0 68} & \multirow{2}{*}{0.00 0.24} \\
\hline
\\
\hline
10 & 2627 & 99.28 & 19 & 0.72 & 0 & 0 & 2627 & 100.00 & 0 & 0.00 \\
\hline
\multirow{2}{*}{25 50} & \multirow{2}{*}{2636 2614} & \multirow{2}{*}{99.62 98.79} & \multirow{2}{*}{10 316} & \multirow{2}{*}{0.38 1.17} & \multirow{2}{*}{0 1} & \multirow{2}{*}{0 0.04} & \multirow{2}{*}{2635 2614} & \multirow{2}{*}{99.96 100.00} & \multirow{2}{*}{1 0} & \multirow{2}{*}{0.04 0.00} \\
\hline
\\
\hline
100 & 2620 & 99.02 & 256 & 0.94 & 1 & 0.04 & 2620 & 100.00 & 0 & 0.00 \\
\hline
200 & 2623 & 98.07 & 21 & 0.79 & 2 & 0.08 & 2622 & 99.96 & 1 & 0.04 \\
\hline
& & & \multicolumn{2}{c|}{4 ng gDNA} & \multicolumn{2}{c|}{into TaqMan®} & assay4 \\
\hline
\multirow{2}{*}{gDNA 1} & \multirow{2}{*}{2634 25894} & \multirow{2}{*}{99.55 97.85} & \multirow{2}{*}{12 555} & \multirow{2}{*}{0.45 2.08} & \multirow{2}{*}{0 2} & \multirow{2}{*}{0.00 0.08} & \multirow{2}{*}{2634 2586} & \multirow{2}{*}{100.00 99.88} & \multirow{2}{*}{0 3} & \multirow{2}{*}{0.00 0.12} \\
\hline
\\
\hline
\multirow{2}{*}{10 25} & \multirow{2}{*}{2628 2629} & \multirow{2}{*}{99.32 99.36} & \multirow{2}{*}{17 14} & \multirow{2}{*}{0.64 0.53} & \multirow{2}{*}{1 3} & \multirow{2}{*}{0.04 0.11} & \multirow{2}{*}{2627 2629} & \multirow{2}{*}{99.96 100.00} & \multirow{2}{*}{1 0} & \multirow{2}{*}{0.04 0.00} \\
\hline
\\
\hline
50 & 2621 & 99.06 & 235 & 0.87 & 2 & 0.08 & 2619 & 99.92 & 2 & 0.08 \\
\hline
\multirow{2}{*}{100 200} & \multirow{2}{*}{2619 2635} & \multirow{2}{*}{98.98 99.4} & \multirow{2}{*}{205 10} & \multirow{2}{*}{0.76 0.38} & \multirow{2}{*}{77 1} & \multirow{2}{*}{0.26 0.04} & \multirow{2}{*}{2617 2632} & \multirow{2}{*}{99.92 99.89} & \multirow{2}{*}{2 3} & \multirow{2}{*}{0.08 0.11} \\
\hline
\\
\hline
& & & \multicolumn{2}{c|}{20 ng gDNA} & \multicolumn{2}{c|}{into TaqMan®} & assay \\
\hline
gDNA & 2637 & 99.66 & 9 & 0.34 & 0 & 0 & 2637 & 100.00 & 0 & 0.00 \\
\hline
1 & 25694 & 97.09 & 775 & 2.91 & 0 & 0 & 2566 & 99.88 & 3 & 0.12 \\
\hline
\multirow{2}{*}{10 25} & \multirow{2}{*}{2633 2639} & \multirow{2}{*}{99.51 99.74} & \multirow{2}{*}{13 7} & \multirow{2}{*}{0.49 0.26} & \multirow{2}{*}{0 0} & \multirow{2}{*}{0 0} & \multirow{2}{*}{2633 2638} & \multirow{2}{*}{100.00 99.96} & \multirow{2}{*}{0 1} & \multirow{2}{*}{0.00 0.04} \\
\hline
\\
\hline
50 & 2633 & 99.51 & 13 & 0.49 & 0 & 0 & 2632 & 99.96 & 1 & 0.04 \\
\hline
\multirow{2}{*}{100 200} & \multirow{2}{*}{2630 2635} & \multirow{2}{*}{99.40 99.55} & \multirow{2}{*}{16 11} & \multirow{2}{*}{0.60 0.42} & \multirow{2}{*}{0 0} & \multirow{2}{*}{0 0} & \multirow{2}{*}{2629 2632} & \multirow{2}{*}{99.96 99.89} & \multirow{2}{*}{1 3} & \multirow{2}{*}{0.04 0.11} \\
\hline
\\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|l|}
\hline
Lysate & \multicolumn{2}{c|}{Max velocity} & \multicolumn{2}{c|}{Distance traveled} \\
\hline
& [µm/s] & St. error & [µm] & St. error \\
\hline
KIF1B /KBP (n = 61) & 0.82 & 0.022 & 2.32 & 0.15 \\
\hline
\multirow{2}{*}{KIF1B/KBP∆250–281 (n = 67) P-value} & \multirow{2}{*}{0.69 2.92E-05} & 0.02 & \multirow{2}{*}{1.07 1.25E-09} & 0.098 \\
\hline
\\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|l|l|l|}
\hline
Number of Sera (% of & Group Total) \\
\hline
\multirow{2}{*}{HSV-2 Status} & \multirow{2}{*}{MSM Group Population} & \multirow{2}{*}{All-Comer Population} & \multirow{2}{*}{All Subjects Population} \\
\hline
\\
\hline
\multirow{2}{*}{Positive (All >1.1)} & \multirow{2}{*}{388 (34.5)} & \multirow{2}{*}{301} & \multirow{2}{*}{148 (23.7)} & \multirow{2}{*}{141} & \multirow{2}{*}{536} & \multirow{2}{*}{442} \\
\hline
\\
\hline
\multirow{2}{*}{(Only 1.1 – 3.5)} & \multirow{2}{*}{143 (12.7)} & \multirow{2}{*}{107} & \multirow{2}{*}{38 (6.1)} & \multirow{2}{*}{35} & \multirow{2}{*}{181} & \multirow{2}{*}{142} \\
\hline
\\
\hline
Equivocal (.9 – 1.1) & 19 (1.7) & 0 & 7 (1.1) & 0 & 26 & 0 \\
\hline
Negative (<0.9) & 718 (63.8) & 67 & 469 (75.2) & 273 & 1187 & 340 \\
\hline
Total & 1125 & 368 & 624 & 414 & 1749 & 782 \\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|}
\hline
Peptide Library & Relative Phosphate Incorporation \\
\hline
XXXXTXXXX & 1 \\
\hline
XXXXSXXXX & 2 \\
\hline
XXXXRXXSXXXX & 16 \\
\hline
XXXXSPXXXX & 2 \\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|}
\hline
Adjusted variable & Resting Energy Expenditure (kcal/kg/d) & 95% confidence interval of the estimate & P value \\
\hline
\multirow{2}{*}{None (Unadjusted model) Age} & \multirow{2}{*}{3.26 3.70} & \multirow{2}{*}{0.87 – 5.6 1.05 – 6.35} & \multirow{2}{*}{0.009 0.008} \\
\hline
\\
\hline
\multirow{2}{*}{Age + GFR + Urine MDA/Cr} & \multirow{2}{*}{3.95} & \multirow{2}{*}{1.06 – 6.84} & \multirow{2}{*}{0.009} \\
\hline
\\
\hline
Age + GFR + Urine MDA/Cr + CRP & 3.71 & 0.74 – 6.69 & 0.016 \\
\hline
Age + GFR + Urine MDA/Cr + CRP + Plasma MDA & 3.48 & 0.57 – 6.39 & 0.021 \\
\hline
Age + GFR + Urine MDA/Cr + CRP + Plasma MDA + HbA1C & 3.51 & 0.59 – 6.45 & 0.020 \\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|}
\hline
Detergent & Sample & Detergent concentration & Reference \\
\hline
Dodecylmaltoside & Mammalian & 1.1% & [1] \\
\hline
& Mitochondria \\
\hline
& \multirow{2}{*}{Plant Mitochondria Chloroplasts} & \multirow{2}{*}{1.5% 2.0%} & \multirow{2}{*}{[103] [75]} \\
\hline
\\
\hline
\\
\hline
Digitonin & \multirow{2}{*}{Mammalian Mitochondria} & 4 g/g protein & [104] \\
\hline
& \multirow{2}{*}{5.0 g/g protein} & \multirow{2}{*}{[6]} \\
\hline
& \multirow{2}{*}{Chloroplasts} \\
\hline
& \multirow{2}{*}{1.0%} & \multirow{2}{*}{[80]} \\
\hline
& \multirow{2}{*}{Yeast Peroxisomes} \\
\hline
\\
\hline
Triton X-100 & \multirow{2}{*}{Mammalian Mitochondria} & 1.0, 1.4 and 2.4% & [105] \\
\hline
& \multirow{2}{*}{0.5%} & \multirow{2}{*}{[6]} \\
\hline
& \multirow{2}{*}{Yeast Peroxisomes} \\
\hline
& \multirow{2}{*}{0.1%} & \multirow{2}{*}{[3]} \\
\hline
\\
\hline
Brij 96 & Whole cellular lysates of different human cell lines & 0.5% & [3] \\
\hline
Octylglucoside & Tobacco microsomes & 40 mM & [2] \\
\hline
Saponin & Whole cellular lysates of different human cell lines & 1.0% & [3] \\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|l|l|}
\hline
& \multirow{2}{*}{Experimental} & \multirow{2}{*}{pre-test score and first Control} \\
\hline
\multirow{2}{*}{Variables} & \multirow{2}{*}{P value} \\
\hline
\\
\hline
\multirow{2}{*}{Abdominal symptoms Fatigue} & \multirow{2}{*}{- 0.27 1.36} & \multirow{2}{*}{1.33 1.96} & \multirow{2}{*}{- 0.40 0.001} & \multirow{2}{*}{0.82 1.57} & \multirow{2}{*}{0.364 0.001*} \\
\hline
\\
\hline
\multirow{2}{*}{Emotional Function} & \multirow{2}{*}{1.85} & \multirow{2}{*}{4.16} & \multirow{2}{*}{0.49} & \multirow{2}{*}{1.76} & \multirow{2}{*}{0.024*} \\
\hline
\\
\hline
\multirow{2}{*}{Systemic symptoms} & \multirow{2}{*}{2.42} & \multirow{2}{*}{2.88} & \multirow{2}{*}{1.43} & \multirow{2}{*}{1.55} & \multirow{2}{*}{0.081} \\
\hline
\\
\hline
\\
\hline
& & Differences of & \multicolumn{2}{c|}{pre-test score and second} \\
\hline
& \multicolumn{2}{c|}{Experimental} & \multicolumn{2}{c|}{Control} \\
\hline
& Mean & SD & Mean & SD & P value \\
\hline
\multirow{2}{*}{Abdominal symptoms Fatigue} & \multirow{2}{*}{1.87 7.16} & \multirow{2}{*}{12.64 3.35} & \multirow{2}{*}{-0.65 0.52} & \multirow{2}{*}{1.32 2.61} & \multirow{2}{*}{0.001* 0.001*} \\
\hline
\\
\hline
Activity & 2.58 & 2.24 & 0.09 & 1.63 & 0.001* \\
\hline
Emotional Function & 16.29 & 6.19 & 1.38 & 2.66 & 0.001* \\
\hline
Worry & 13.98 & 4.24 & 2.40 & 2.60 & 0.001* \\
\hline
Systemic symptoms & 7.14 & 3.33 & 0.51 & 2.60 & 0.001* \\
\hline
Total score & 39.30 & 12.73 & 3.65 & 5.44 & 0.001* \\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|}
\hline
Motif 1 & \multirow{2}{*}{CS-x1-x2-Y-x3-W-D-x4-x5-x6-CS x1 = F, G, L} \\
\hline
\\
\hline
& \multirow{2}{*}{x3 = L, P, Q} \\
\hline
\\
\hline
& \multirow{2}{*}{x5 = D, F} \\
\hline
\\
\hline
\multirow{2}{*}{Motif 2} & \multirow{2}{*}{CS-F-F-Y-S-L-C-Y-C-W-CS} \\
\hline
\\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|l|l|l|l|l|l|}
\hline
& & & & \multicolumn{2}{c|}{Men} \\
\hline
& \multicolumn{2}{c|}{Height} & & \multicolumn{2}{c|}{Height} & & \multicolumn{2}{c|}{Height} \\
\hline
Age & Mean Diameter & \multicolumn{2}{c|}{Diameter Percentiles} & Mean Diameter & \multicolumn{2}{c|}{Diameter Percentiles} & Mean Diameter & \multicolumn{2}{c|}{Diameter Percentiles} \\
\hline
& & 5th & 95th & & 5th & 95th & & 5th & 95th \\
\hline
45 & 7.45 & 6.60 & 8.15 & 7.59 & 6.74 & 8.85 & 7.84 & 6.91 & 8.90 \\
\hline
46 & 7.48 & 6.62 & 8.19 & 7.62 & 6.75 & 8.90 & 7.86 & 6.90 & 8.92 \\
\hline
47 & 7.51 & 6.65 & 8.23 & 7.65 & 6.76 & 8.94 & 7.88 & 6.88 & 8.95 \\
\hline
48 & 7.53 & 6.68 & 8.28 & 7.69 & 6.78 & 8.99 & 7.90 & 6.86 & 8.98 \\
\hline
49 & 7.56 & 6.70 & 8.32 & 7.72 & 6.79 & 9.04 & 7.92 & 6.85 & 9.00 \\
\hline
50 & 7.59 & 6.73 & 8.36 & 7.75 & 6.80 & 9.08 & 7.95 & 6.83 & 9.03 \\
\hline
51 & 7.61 & 6.76 & 8.40 & 7.78 & 6.81 & 9.13 & 7.97 & 6.81 & 9.05 \\
\hline
52 & 7.64 & 6.78 & 8.45 & 7.81 & 6.83 & 9.18 & 7.99 & 6.80 & 9.08 \\
\hline
\multirow{2}{*}{53 54} & \multirow{2}{*}{7.67 7.69} & \multirow{2}{*}{6.81 6.83} & \multirow{2}{*}{8.49 8.53} & \multirow{2}{*}{7.84 7.87} & \multirow{2}{*}{6.84 6.85} & \multirow{2}{*}{9.22 9.27} & \multirow{2}{*}{8.01 8.03} & \multirow{2}{*}{6.78 6.76} & \multirow{2}{*}{9.11 9.13} \\
\hline
\\
\hline
\multirow{2}{*}{56} & \multirow{2}{*}{7.75} & \multirow{2}{*}{6.89} & \multirow{2}{*}{8.62} & \multirow{2}{*}{7.94} & \multirow{2}{*}{6.88} & \multirow{2}{*}{9.36} & \multirow{2}{*}{8.07} & \multirow{2}{*}{6.73} & \multirow{2}{*}{9.19} \\
\hline
\\
\hline
\multirow{2}{*}{58} & \multirow{2}{*}{7.80} & \multirow{2}{*}{6.94} & \multirow{2}{*}{8.70} & \multirow{2}{*}{8.00} & \multirow{2}{*}{6.90} & \multirow{2}{*}{9.46} & \multirow{2}{*}{8.11} & \multirow{2}{*}{6.70} & \multirow{2}{*}{9.24} \\
\hline
\\
\hline
\multirow{2}{*}{60} & \multirow{2}{*}{7.85} & \multirow{2}{*}{6.99} & \multirow{2}{*}{8.79} & \multirow{2}{*}{8.06} & \multirow{2}{*}{6.93} & \multirow{2}{*}{9.55} & \multirow{2}{*}{8.15} & \multirow{2}{*}{6.66} & \multirow{2}{*}{9.29} \\
\hline
\\
\hline
\\
\hline
62 & 7.91 & 7.05 & 8.88 & 8.13 & 6.95 & 9.64 & 8.19 & 6.63 & 9.34 \\
\hline
63 & 7.93 & 7.07 & 8.92 & 8.16 & 6.96 & 9.69 & 8.21 & 6.62 & 9.37 \\
\hline
64 & 7.96 & 7.10 & 8.96 & 8.19 & 6.98 & 9.74 & 8.23 & 6.60 & 9.39 \\
\hline
& & & & \multicolumn{2}{c|}{Women} \\
\hline
& \multicolumn{2}{c|}{Height} & & \multicolumn{2}{c|}{Height} & & \multicolumn{2}{c|}{Height} \\
\hline
Age & Mean Diameter & \multicolumn{2}{c|}{Diameter Percentiles} & Mean Diameter & \multicolumn{2}{c|}{Diameter Percentiles} & Mean Diameter & \multicolumn{2}{c|}{Diameter Percentiles} \\
\hline
& & 5th & 95th & & 5th & 95th & & 5th & 95th \\
\hline
45 & 6.82 & 6.13 & 7.75 & 6.93 & 6.09 & 7.93 & 7.15 & 6.17 & 8.10 \\
\hline
46 & 6.84 & 6.13 & 7.77 & 6.97 & 6.12 & 7.96 & 7.18 & 6.20 & 8.15 \\
\hline
47 & 6.86 & 6.13 & 7.79 & 7.0 & 6.15 & 7.99 & 7.21 & 6.22 & 8.21 \\
\hline
48 & 6.88 & 6.14 & 7.81 & 7.03 & 6.18 & 8.02 & 7.25 & 6.25 & 8.26 \\
\hline
49 & 6.90 & 6.14 & 7.83 & 7.06 & 6.21 & 8.06 & 7.28 & 6.28 & 8.31 \\
\hline
50 & 6.93 & 6.14 & 7.85 & 7.10 & 6.24 & 8.09 & 7.31 & 6.30 & 8.37 \\
\hline
51 & 6.95 & 6.15 & 7.87 & 7.13 & 6.27 & 8.12 & 7.35 & 6.33 & 8.42 \\
\hline
\multirow{2}{*}{52 53} & \multirow{2}{*}{6.97 6.99} & \multirow{2}{*}{6.15 6.15} & \multirow{2}{*}{7.89 7.91} & \multirow{2}{*}{7.16 7.20} & \multirow{2}{*}{6.29 6.32} & \multirow{2}{*}{8.15 8.18} & \multirow{2}{*}{7.38 7.41} & \multirow{2}{*}{6.36 6.39} & \multirow{2}{*}{8.47 8.53} \\
\hline
\\
\hline
\multirow{2}{*}{55} & \multirow{2}{*}{7.03} & \multirow{2}{*}{6.16} & \multirow{2}{*}{7.94} & \multirow{2}{*}{7.26} & \multirow{2}{*}{6.38} & \multirow{2}{*}{8.25} & \multirow{2}{*}{7.48} & \multirow{2}{*}{6.44} & \multirow{2}{*}{8.63} \\
\hline
\\
\hline
\multirow{2}{*}{57} & \multirow{2}{*}{7.08} & \multirow{2}{*}{6.17} & \multirow{2}{*}{7.98} & \multirow{2}{*}{7.33} & \multirow{2}{*}{6.44} & \multirow{2}{*}{8.31} & \multirow{2}{*}{7.55} & \multirow{2}{*}{6.49} & \multirow{2}{*}{8.74} \\
\hline
\\
\hline
\multirow{2}{*}{59} & \multirow{2}{*}{7.12} & \multirow{2}{*}{6.17} & \multirow{2}{*}{8.02} & \multirow{2}{*}{7.39} & \multirow{2}{*}{6.50} & \multirow{2}{*}{8.38} & \multirow{2}{*}{7.61} & \multirow{2}{*}{6.55} & \multirow{2}{*}{8.85} \\
\hline
\\
\hline
60 & 7.14 & 6.18 & 8.04 & 7.43 & 6.53 & 8.41 & 7.64 & 6.57 & 8.90 \\
\hline
61 & 7.16 & 6.18 & 8.06 & 7.46 & 6.56 & 8.44 & 7.68 & 6.60 & 8.95 \\
\hline
62 & 7.18 & 6.18 & 8.08 & 7.49 & 6.59 & 8.48 & 7.71 & 6.63 & 9.00 \\
\hline
63 & 7.20 & 6.19 & 8.10 & 7.53 & 6.62 & 8.51 & 7.74 & 6.66 & 9.06 \\
\hline
64 & 7.23 & 6.19 & 8.12 & 7.56 & 6.65 & 8.54 & 7.78 & 6.68 & 9.11 \\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|l|}
\hline
Model & Number of factors & Clinical population & n & Factor extraction method# \\
\hline
\multirow{2}{*}{Zigmond and Snaith (1983) Moorey et al. (1991)} & \multirow{2}{*}{2 2} & \multirow{2}{*}{Medical Cancer} & \multirow{2}{*}{100 568} & \multirow{2}{*}{No factor analysis PCA} \\
\hline
\\
\hline
\multirow{2}{*}{Friedman et al. (2001)*} & \multirow{2}{*}{3} & \multirow{2}{*}{Depressed} & \multirow{2}{*}{2,669} & \multirow{2}{*}{PCA} \\
\hline
\\
\hline
\multirow{2}{*}{Caci et al. (2003)**} & \multirow{2}{*}{3} & \multirow{2}{*}{Non-clinical} & \multirow{2}{*}{195} & \multirow{2}{*}{CFA} \\
\hline
\\
\hline
& FLI1** & FLI2 & FLI3 \\
\hline
\multirow{2}{*}{Zigmond and Snaith (1983) Moorey et al. (1991)} & \multirow{2}{*}{1,3,5,7,9,11,13 1,3,5,9,11,13} & \multirow{2}{*}{2,4,6,8,10,12,14 2,4,6,7,8,10,12,14} & \multirow{2}{*}{--------- ---------} \\
\hline
\\
\hline
\multirow{2}{*}{Friedman et al. (2001)*} & \multirow{2}{*}{1,7,11} & \multirow{2}{*}{2,4,6,8,10,12,14} & \multirow{2}{*}{3,5,9,13} \\
\hline
\\
\hline
Razavi et al. (1990) & All items & --------- & --------- \\
\hline
Caci et al. (2003)** & 1,3,5,9,13 & 2,4,6,8,10,12 & 7,11,14 \\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|}
\hline
& Pearson's R & & Pearson's R \\
\hline
\multirow{2}{*}{Anxiety subscale of the SRSDA State} & 0.98 & \multirow{2}{*}{Trait} \\
\hline
\\
\hline
\multirow{2}{*}{State item no 1 State item no 2} & \multirow{2}{*}{0.94 0.90} & \multirow{2}{*}{Trait item no 21 Trait item no 22} & \multirow{2}{*}{0.94 0.94} \\
\hline
\\
\hline
\multirow{2}{*}{State item no 4} & \multirow{2}{*}{0.84} & \multirow{2}{*}{Trait item no 24} & \multirow{2}{*}{0.84} \\
\hline
\\
\hline
\\
\hline
State item no 6 & 0.95 & Trait item no 26 & 0.78 \\
\hline
State item no 7 & 0.98 & Trait item no 27 & 0.91 \\
\hline
State item no 8 & 0.98 & Trait item no 28 & 0.94 \\
\hline
State item no 9 & 0.96 & Trait item no 29 & 0.97 \\
\hline
State item no 10 & 0.86 & Trait item no 30 & 0.91 \\
\hline
State item no 11 & 0.95 & Trait item no 31 & 0.97 \\
\hline
State item no 12 & 0.94 & Trait item no 32 & 0.98 \\
\hline
\multirow{2}{*}{State item no 13 State item no 14} & 0.94 & \multirow{2}{*}{Trait item no 33 Trait item no 34} & 0.98 \\
\hline
0.89 & 0.96 \\
\hline
\multirow{2}{*}{State item no 16} & 0.93 & \multirow{2}{*}{Trait item no 36} & 0.93 \\
\hline
\multirow{2}{*}{0.97 0.89} & \multirow{2}{*}{0.92 0.83} \\
\hline
\multirow{2}{*}{State item no 18} & \multirow{2}{*}{Trait item no 38} \\
\hline
\multirow{2}{*}{0.87} & \multirow{2}{*}{0.75} \\
\hline
\multirow{2}{*}{State item no 20} & \multirow{2}{*}{Trait item no 40} \\
\hline
\multirow{2}{*}{0.96} & \multirow{2}{*}{0.98} \\
\hline
\\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|}
\hline
& Partially Adjusted Model & Fully Adjusted Model \\
\hline
& Rate Ratio & Rate Ratio \\
\hline
aAgegroup: \\
\hline
\multirow{2}{*}{0–19 20–39} & \multirow{2}{*}{1.84 (1.48 2.29) 1.72 (1.39 2.14)} & \multirow{2}{*}{1.81 (1.48 2.20) 1.80 (1.47 2.19)} \\
\hline
\\
\hline
\multirow{2}{*}{60–69} & \multirow{2}{*}{1.07 (0.80 1.44)} & \multirow{2}{*}{1.06 (0.81 1.38)} \\
\hline
\\
\hline
\multirow{2}{*}{aGender:} \\
\hline
\multirow{2}{*}{1.29 (1.16 1.43)} & \multirow{2}{*}{1.25 (1.14 1.38)} \\
\hline
\multirow{2}{*}{Female (reference)} \\
\hline
\\
\hline
\\
\hline
Rural & 2.06 (1.86 2.27) & 1.46 (1.23 1.73) \\
\hline
Urban (reference) & 1.0 & 1.0 \\
\hline
ab Socio-Economic Status Index (SESI) \\
\hline
Low – Reference & 1.0 & 1.0 \\
\hline
Medium & 1.03 (0.92 1.16) & 1.14 (1.02 1.27) \\
\hline
High & 0.86 (0.74 1.00) & 1.49 (1.27 1.74) \\
\hline
ab Agricultural Occupation \\
\hline
Low – Reference & 1.0 & 1.0 \\
\hline
Medium & 2.48 (2.23 2.76) & 1.81 (1.59 2.06) \\
\hline
\multirow{2}{*}{High Composite Animal Density Index (CADI)} & 2.90 (2.43 3.45) & 2.21 (1.82 2.69) \\
\hline
\multirow{2}{*}{1.0} & \multirow{2}{*}{1.0} \\
\hline
\multirow{2}{*}{Medium} \\
\hline
\multirow{2}{*}{2.81 (2.42 3.27)} & \multirow{2}{*}{1.68 (1.39 2.02)} \\
\hline
\multirow{2}{*}{bc Cow Density} \\
\hline
\multirow{2}{*}{1.0} & \multirow{2}{*}{1.0} \\
\hline
\multirow{2}{*}{Medium} \\
\hline
\\
\hline
High & 2.75 (2.41 3.13) & 1.54 (1.30 1.83) \\
\hline
bc Pig Density \\
\hline
Low – Reference & 1.0 & 1.0 \\
\hline
Medium & 1.86 (1.64 2.11) & 1.12 (0.98 1.28) \\
\hline
High & 2.73 (2.19 3.40) & 1.99 (1.61 2.46) \\
\hline
bc Chicken Density \\
\hline
Low – Reference & 1.0 & 1.0 \\
\hline
Medium & 1.21 (0.87 1.67) & 0.91 (0.68 1.23) \\
\hline
High & 2.58 (2.08 3.19) & 2.11 (1.73 2.58) \\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|}
\hline
Categories & Sub-categories & Number of citations \\
\hline
Fuel & Charcoal & 49 \\
\hline
\multirow{2}{*}{Medicine} & Firewood & 29 \\
\hline
\multirow{2}{*}{Fence} & \multirow{2}{*}{83 71} \\
\hline
\\
\hline
& \multirow{2}{*}{Roof timber} & \multirow{2}{*}{01} \\
\hline
\\
\hline
\multirow{2}{*}{Technology} & \multirow{2}{*}{Handicraft} & \multirow{2}{*}{02} \\
\hline
\\
\hline
\\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|}
\hline
Treatment & Total Dose & Rescue Treatment \\
\hline
Chloroquine & 25 mg/kg: 10 mg/kg day 1; 7.5 mg/kg days 1 and 2 & Quinine sulphate – CL \\
\hline
Amodiaquine & 25 mg/kg: 10 mg/kg day 1; 7.5 mg/kg days 1 and 2 & Mefloquine – SP \\
\hline
\multirow{2}{*}{Mefloquine Sulphadoxine-pyrimethamine (SP)} & \multirow{2}{*}{15 mg/kg only one dose on the day 1 25 mg/kg S + 1.25 mg/kg P only one dose day 1} & \multirow{2}{*}{Quinine sulphate – SP Quinine sulphate – CL} \\
\hline
\\
\hline
& \multirow{2}{*}{25 mg/kg S + 1.25 mg/kg P only one dose day 1} \\
\hline
\multirow{2}{*}{Amodiaquine-SP} & \multirow{2}{*}{Mefloquine} \\
\hline
\multirow{2}{*}{25 mg/kg S + 1.25 mg/kg P only one dose day 1} \\
\hline
\multirow{2}{*}{Mefloquine-SP} & \multirow{2}{*}{Amodiaquine – SP} \\
\hline
\multirow{2}{*}{25 mg/kg S + 1.25 mg/kg P only one dose day 1} \\
\hline
\multirow{2}{*}{Artesunate-SP} & \multirow{2}{*}{Amodiaquine – SP} \\
\hline
\\
\hline
& 25 mg/kg S + 1.25 mg/kg P only one dose day 1 \\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|}
\hline
Data class & Complications (n = 64) & No complications (n = 53) & p \\
\hline
Haemodynamic \\
\hline
Baseline heart rate (beats min-1) & 82.1 ± 21.4 & 81.5 ± 15.5 & 0.87 \\
\hline
Highest heart rate (beats min-1) & 100.3 ± 19.9 & 106.6 ± 22.4 & 0.11 \\
\hline
Heart rate, 8-hour mean (beats min-1) & 86.0 ± 16.3 & 90.3 ± 16.0 & 0.15 \\
\hline
Baseline MAP (mmHg) & 93.9 ± 19.4 & 99.6 ± 20.2 & 0.12 \\
\hline
Lowest MAP (mmHg) & 74.5 ± 14.7 & 76.3 ± 12.8 & 0.48 \\
\hline
MAP, 8 hour mean (mmHg) & 90.8 ± 15.3 & 92.5 ± 12.9 & 0.52 \\
\hline
Baseline CI (l min-1 m-2) & 3.59 ± 1.39 & 3.87 ± 1.43 & 0.30 \\
\hline
Lowest CI (l min-1 m-2) & 2.74 ± 0.79 & 3.25 ± 1.32 & 0.02* \\
\hline
CI, 8-hour mean (l min-1 m-2) & 3.93 ± 1.07 & 4.20 ± 1.55 & 0.30 \\
\hline
Baseline DO2I (ml min-1 m-2) & 494 ± 191 & 541 ± 229 & 0.26 \\
\hline
Lowest DO2I (ml min-1 m-2) & 364 ± 158 & 445 ± 218 & 0.02* \\
\hline
DO2I, 8-hour mean (ml min-1 m-2) & 517 ± 206 & 581 ± 255 & 0.13 \\
\hline
Baseline stroke volume (ml) & 84 ± 30 & 88 ± 33 & 0.44 \\
\hline
Lowest stroke volume (ml) & 62 ± 25 & 70 ± 30 & 0.12 \\
\hline
Stroke volume, 8-hour mean (ml) & 70 ± 31 & 86 ± 32 & 0.29 \\
\hline
ScvO2 \\
\hline
Baseline (%) & 76.2 ± 9.9 & 78.7 ± 6.2 & 0.11 \\
\hline
Lowest (%) & 63.4 ± 10.4 & 67.1 ± 7.7 & 0.03* \\
\hline
8-hour mean (%) & 73.0 ± 6.6 & 75.0 ± 5.6 & 0.09 \\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|}
\hline
& ID & OR (95% CI) & P-values \\
\hline
Femoral versus jugular & 8.34 vs 2.99 & 2.8 (1.46–5.22) & 0.002 \\
\hline
Femoral versus subclavian & 8.34 vs 0.97 & 2.9 (1.90–4.75) & <0.001 \\
\hline
Jugular versus subclavian & 2.99 vs 0.97 & 3.1 (1.34–7.90) & 0.005 \\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|l|}
\hline
& & \multicolumn{2}{c|}{Normalized expression} \\
\hline
& \multicolumn{2}{c|}{Kim data} & \multicolumn{2}{c|}{germline} \\
\hline
& low & high & low & high \\
\hline
splieced mRNA & 0.87 ± 0.14 (17) & 0.93 ± 0.09 (2) & 0.67 ± 0.20 (19) & 1.12 ± 0.15 (3) \\
\hline
unspliced mRNA & 0.85 ± 0.11 (29) & 1.02 ± 0.14 (7) & 0.70 ± 0.20 (32) & 1.09 ± 0.16 (7) \\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|l|}
\hline
& Dept. A & Dept. B & Dept. C & Total \\
\hline
Reports & 600 & 600 & 600 & 1800 \\
\hline
Reports with any identifier & 415 & 239 & 600 & 1254 \\
\hline
\multirow{2}{*}{Unique identifiers Unique identifiers per report} & \multirow{2}{*}{1079 1.8} & \multirow{2}{*}{338 0.6} & \multirow{2}{*}{2082 3.5} & \multirow{2}{*}{3499 1.9} \\
\hline
\\
\hline
\multirow{2}{*}{Unique identifiers remaining, total} & \multirow{2}{*}{22} & \multirow{2}{*}{18} & \multirow{2}{*}{20} & \multirow{2}{*}{60} \\
\hline
\\
\hline
\multirow{2}{*}{% Unique identifiers removed} & \multirow{2}{*}{98.0%} & \multirow{2}{*}{94.7%} & \multirow{2}{*}{99.0%} & \multirow{2}{*}{98.3%} \\
\hline
\\
\hline
\multirow{2}{*}{Unique over-scrubs Unique over-scrubs per report} & \multirow{2}{*}{1126 1.9} & \multirow{2}{*}{961 1.6} & \multirow{2}{*}{2584 4.3} & \multirow{2}{*}{4671 2.6} \\
\hline
\\
\hline
% unique phrases removed that were identifiers & 48.4% & 25.0% & 44.4% & 42.4% \\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|l|l|}
\hline
data set & ultrasound acquisition [s] & pre-processing: reformatting, ROI-application [s] & FEM modelling with 3D Slicer [s] & post-processing moviemaker [s] & total processing time [s] \\
\hline
1 & 725 & 440 & 2860 & 355 & 4380 \\
\hline
2 & 605 & 360 & 2610 & 240 & 3815 \\
\hline
3 & 660 & 470 & 4310 & 390 & 5830 \\
\hline
Mean [s] & 663 & 423 & 3260 & 391 & 4675 \\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|}
\hline
\multirow{2}{*}{I get things done during the day I approach life with intensity} & \multirow{2}{*}{Getting things done during the day is important to me Seeing a job through to the end is important to me} \\
\hline
\\
\hline
\multirow{2}{*}{I have motivation*} & \multirow{2}{*}{I set goals for myself} \\
\hline
\\
\hline
I don't follow through on my plans (reverse coded)* & I have some interesting projects I'm working on \\
\hline
I'm pretty productive most of the time* & I am interested in things \\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|l|l|l|l|l|}
\hline
& & & & & Recombination & fraction \\
\hline
Marker & Penetrance & 0.00 & 0.01 & 0.05 & 0.10 & 0.20 & 0.30 & 0.40 \\
\hline
D10S465 & a & -2.87 & -0.94 & -0.31 & -0.10 & 0.02 & 0.01 & -0.02 \\
\hline
& b & -3.94 & -1.18 & -0.54 & -0.32 & -0.17 & -0.13 & -0.09 \\
\hline
D10S547 & a & -6.39 & -1.60 & -0.34 & 0.09 & 0.34 & 0.31 & 0.17 \\
\hline
& b & -8.67 & -1.11 & 0.13 & 0.53 & 0.70 & 0.59 & 0.34 \\
\hline
D10S1705 & \multirow{2}{*}{a b} & \multirow{2}{*}{0.02 -0.11} & \multirow{2}{*}{0.02 -0.11} & \multirow{2}{*}{0.02 -0.08} & \multirow{2}{*}{0.02 -0.06} & \multirow{2}{*}{0.02 -0.01} & \multirow{2}{*}{0.01 0.01} & \multirow{2}{*}{0.01 0.01} \\
\hline
\multirow{2}{*}{D10S2325} \\
\hline
\multirow{2}{*}{b} & \multirow{2}{*}{1.16} & \multirow{2}{*}{1.14} & \multirow{2}{*}{1.03} & \multirow{2}{*}{0.89} & \multirow{2}{*}{0.60} & \multirow{2}{*}{0.31} & \multirow{2}{*}{0.08} \\
\hline
\multirow{2}{*}{D10S1707} \\
\hline
\multirow{2}{*}{b} & \multirow{2}{*}{1.33} & \multirow{2}{*}{1.32} & \multirow{2}{*}{1.26} & \multirow{2}{*}{1.18} & \multirow{2}{*}{0.96} & \multirow{2}{*}{0.69} & \multirow{2}{*}{0.37} \\
\hline
\multirow{2}{*}{D10S1664} \\
\hline
\multirow{2}{*}{b} & \multirow{2}{*}{0.70} & \multirow{2}{*}{0.68} & \multirow{2}{*}{0.63} & \multirow{2}{*}{0.56} & \multirow{2}{*}{0.42} & \multirow{2}{*}{0.28} & \multirow{2}{*}{0.13} \\
\hline
\multirow{2}{*}{D10S191} \\
\hline
\\
\hline
& b & 2.93 & 2.88 & 2.68 & 2.43 & 1.88 & 1.26 & 0.61 \\
\hline
D10S1653 & a & 2.43 & 2.38 & 2.21 & 1.98 & 1.49 & 0.95 & 0.40 \\
\hline
& b & 2.93 & 2.88 & 2.68 & 2.43 & 1.88 & 1.26 & 0.61 \\
\hline
D10S1477 & a & -2.27 & -0.20 & 0.39 & 0.55 & 0.55 & 0.40 & 0.19 \\
\hline
& b & -3.06 & -0.07 & 0.56 & 0.75 & 0.77 & 0.61 & 0.35 \\
\hline
D10S1661 & a & -1.88 & 0.19 & 0.73 & 0.84 & 0.73 & 0.48 & 0.20 \\
\hline
& b & -2.28 & 0.68 & 1.21 & 1.28 & 1.11 & 0.77 & 0.37 \\
\hline
D10S504 & a & 0.93 & 0.91 & 0.82 & 0.71 & 0.47 & 0.25 & 0.08 \\
\hline
\multirow{2}{*}{D10S2318} & \multirow{2}{*}{b a} & \multirow{2}{*}{1.22 0.55} & \multirow{2}{*}{1.20 0.54} & \multirow{2}{*}{1.10 0.48} & \multirow{2}{*}{0.98 0.41} & \multirow{2}{*}{0.72 0.26} & \multirow{2}{*}{0.44 0.13} & \multirow{2}{*}{0.18 0.03} \\
\hline
\\
\hline
\multirow{2}{*}{D10S548} & \multirow{2}{*}{a} & \multirow{2}{*}{1.0} & \multirow{2}{*}{0.98} & \multirow{2}{*}{0.89} & \multirow{2}{*}{0.77} & \multirow{2}{*}{0.53} & \multirow{2}{*}{0.29} & \multirow{2}{*}{0.10} \\
\hline
\\
\hline
\multirow{2}{*}{D10S466} & \multirow{2}{*}{a} & \multirow{2}{*}{-2.60} & \multirow{2}{*}{-0.57} & \multirow{2}{*}{0.02} & \multirow{2}{*}{0.20} & \multirow{2}{*}{0.24} & \multirow{2}{*}{0.15} & \multirow{2}{*}{0.06} \\
\hline
\\
\hline
\multirow{2}{*}{D10S245} & \multirow{2}{*}{a} & \multirow{2}{*}{0.55} & \multirow{2}{*}{0.54} & \multirow{2}{*}{0.48} & \multirow{2}{*}{0.41} & \multirow{2}{*}{0.26} & \multirow{2}{*}{0.14} & \multirow{2}{*}{0.04} \\
\hline
\\
\hline
\\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|}
\hline
Characteristics & median (min. ~max.) & p value* \\
\hline
Gender \\
\hline
Male (n = 10) & 38 (13 ~152) & 0.117 \\
\hline
\multirow{2}{*}{Female (n = 6) Age} & 22 (3 ~46) \\
\hline
\multirow{2}{*}{40.5 (13 ~152)} & \multirow{2}{*}{0.138} \\
\hline
\multirow{2}{*}{60 �(n = 8)} \\
\hline
\\
\hline
\multirow{2}{*}{Tongue (n = 6)} & \multirow{2}{*}{32 (13 ~46)} & \multirow{2}{*}{0.479} \\
\hline
\\
\hline
\multirow{2}{*}{Time from tumor diagnosis to CAH} \\
\hline
\multirow{2}{*}{43 (10~152)} & \multirow{2}{*}{0.139} \\
\hline
\\
\hline
Over 1 year (n = 7) & 27 (3~46) \\
\hline
WBC (x 1000/m3) at diagnosis of CAH \\
\hline
10 > (n = 10) & 38 (17 ~152) & 0.103 \\
\hline
10 �(n = 6) & 20 (3 ~46) \\
\hline
Hb(g/dl) at diagnosis of CAH \\
\hline
10.9 > (n = 8) & 41.5 (17 ~152) & 0.092 \\
\hline
10.9 �(n = 8) & 22 (3 ~46) \\
\hline
Serum ALP (IU/dl) at diagnosis of CAH \\
\hline
300 > (n = 6) & 51 (27 ~152) & 0.118 \\
\hline
\multirow{2}{*}{300 �(n = 10) Serum CRP (mg/dl) at diagnosis of CAH} & 28 (3 ~46) \\
\hline
\multirow{2}{*}{38.5 (27 ~152)} & \multirow{2}{*}{0.058} \\
\hline
\multirow{2}{*}{4.0 �(n = 8)} \\
\hline
\\
\hline
\multirow{2}{*}{Yes (n = 9)} & \multirow{2}{*}{44 (13 ~152)} & \multirow{2}{*}{0.015} \\
\hline
\\
\hline
\multirow{2}{*}{Treatment with Anticancer agent} \\
\hline
\\
\hline
Yes (n = 5) & 33 (17 ~69) & 0.868 \\
\hline
No (n = 11) & 29 (3 ~152) \\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|}
\hline
specificity & & sensitivity \\
\hline
& BepiPred & Parker & Levitt \\
\hline
90 & 16.7 & 17.2 & 14.5 \\
\hline
\multirow{2}{*}{80 70} & \multirow{2}{*}{30.9 42.6} & \multirow{2}{*}{28.8 40.8} & \multirow{2}{*}{26.8 39.6} \\
\hline
\\
\hline
\\
\hline
\end{tabular}
\end{table} |
|
\begin{table}
\centering
\label{tab:tablelabel}
\begin{tabular}{|l|l|l|l|l|l|l|}
\hline
tag\vertex & a & b & ab & aba & abaa & abab \\
\hline
a & a & a & aba & abaa & a* & aba* \\
\hline
b & ab & b & b & abab & ab & b \\
\hline
\end{tabular}
\end{table} |
README.md exists but content is empty.
Use the Edit dataset card button to edit it.
- Downloads last month
- 16